AGA Clinical Practice Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation in At-Risk Individuals Post author:GIBoardReview.com Post published:February 14, 2025 Post category:Society Guidelines You Might Also Like AGA Clinical Practice Update on the Use of Vasoactive Drugs and Intravenous Albumin in Cirrhosis: Expert Review December 29, 2023 ACG Clinical Guidelines: Prevention, Diagnosis, and Treatment of Clostridioides difficile Infections December 29, 2021 ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease November 22, 2021
AGA Clinical Practice Update on the Use of Vasoactive Drugs and Intravenous Albumin in Cirrhosis: Expert Review December 29, 2023
ACG Clinical Guidelines: Prevention, Diagnosis, and Treatment of Clostridioides difficile Infections December 29, 2021
ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease November 22, 2021